Characterization of lipoproteins during human cholestasis

被引:11
作者
Tallet, F
Vasson, MP
Couderc, R
Lefevre, G
Raichvarg, D
机构
[1] HOP TENON,SERV BIOCHIM,F-75020 PARIS,FRANCE
[2] HOP COCHIN,SERV BIOCHIM A,F-75014 PARIS,FRANCE
[3] FAC PHARM,SERV BIOCHIM,F-63000 CLERMONT FERRAND,FRANCE
关键词
lipoprotein; low density lipoprotein; high density lipoprotein; cholestasis; bile salts;
D O I
10.1016/0009-8981(95)06161-4
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We have characterized changes in lipoproteins from cholestatic individuals and reproduced them by incubating lipoproteins from healthy individuals with cholic acid. The cholestatic patients showed an increase in low density lipoprotein (LDL) (> 85%), with a smaller proportion of esterified cholesterol, and a fall in high density lipoprotein (HDL) (< 10%), with a larger proportion of phospholipids. The protein composition of cholestatic HDL(1) was characterized by a smaller proportion of apo A (I, II) and a prominent apo E fraction (39% vs. 9%). These changes involved an increase in degree of molecular packing (order) of HDL(1). The addition of cholic acid to serum from healthy individuals altered the lipoprotein distribution, with an increase in LDL, the disappearance of HDL(2) and HDL(3) and the appearance of HDL(1). These HDL(1) were characterized by increased phospholipid and reduced apo AI fractions. They also showed a lower density and appeared as spherical particles in contrast to cholestatic HDL. Incubation of healthy HDL with cholic acid in vitro reproduces some of the alteration observed in cholestatic HDL.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 21 条
[1]   CHARACTERIZATION OF HIGH-DENSITY LIPOPROTEINS IN HUMAN CHOLESTASIS [J].
ARNESJO, B ;
DANIELSSON, B ;
EKMAN, R ;
JOHANSSON, BG ;
PETERSSON, BG .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1977, 37 (07) :587-597
[2]  
BRUNETCOULHON MP, 1985, CLIN CHIM ACTA, V145, P163
[3]  
CASTRO GR, 1984, J LIPID RES, V25, P58
[4]   SPURIOUS ELEVATION OF SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN PATIENTS WITH CHOLESTATIC LIVER-DISEASES [J].
CHIBA, H ;
OSAKA, T ;
IWASAKI, N ;
SUZUKI, H ;
AKIZAWA, K ;
FUJISAWA, S ;
INTOH, S ;
WATANABE, M ;
YOSHIDA, J ;
MATSUNO, K ;
MITAMURA, T ;
KOBAYASHI, K .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1991, 46 (03) :329-343
[5]  
CLIFTON PM, 1988, J LIPID RES, V29, P121
[6]  
EDELSTEIN C, 1986, METHOD ENZYMOL, V128, P151
[7]   APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-A-II AND APOLIPOPROTEIN-E IN CHOLESTATIC LIVER-DISEASE [J].
FLOREN, CH ;
GUSTAFSON, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 (02) :103-108
[8]   PLASMA LIPOPROTEINS IN FAMILIAL LECITHIN-CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - STRUCTRUE OF LOW AND HIGH DENSITY LIPOPROTEINS AS REVEALED BY ELECTRON MICROSCOPY [J].
FORTE, T ;
NORUM, KR ;
GLOMSET, JA ;
NICHOLS, AV .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (05) :1141-&
[9]  
FUJII S, 1981, CLIN CHIM ACTA, V115, P321
[10]  
GOLDBERG CS, 1984, J LIPID RES, V25, P714